DICERNA
"DICERNA" is a word mark owned by Dicerna Pharmaceuticals, Inc., filed at the CIPO on November 9, 2018. It is registered and covers classes 5 and 42.
- Status
- Registered
- Since December 5, 2022
- Filed
- November 9, 2018
- Registered
- December 5, 2022
- Expires
- December 5, 2032
- Application no.
- 1929867
- Registration no.
- TMA1154694
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 2 classes
Who owns DICERNA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Dicerna Pharmaceuticals, Inc.
United States
Representative
CPST Intellectual Property Inc.
CPST Intellectual Property Inc.
What the mark covers
The products and services DICERNA is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of various diseases, namely, rare metabolic, endocrine, cardiac, oncological, gastrointestinal, nephrological, autoimmune, and neurological diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare metabolic, endocrine, cardiac, oncological, gastrointestinal, nephrological, autoimmune, and neurological diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development for the treatment of various diseases, namely rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and cancers and viral infections; scientific investigations in the fields of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and cancers and viral infections for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
What has happened so far
Steps recorded by the CIPO, newest first.
- Registered
- Registration Fee Notice Sent
- Registration Pending
- Advertised; Vol.69 Issue 3520
- Approval Notice Sent; APPROVED BY PROGRAM EX200M1
- Approved; APPROVED BY PROGRAM EX200M1
- Default Removed
- Default Notice Sent
- Agent Changed; From: 92 To: 23264 / Voir Preuve au dossier/See evidence on File No. 1929863
- Examiner's First Report
4 earlier steps on the official record.
About DICERNA
Who owns the trademark "DICERNA"?
The CIPO trademark "DICERNA" (application 1929867) is owned by Dicerna Pharmaceuticals, Inc.
What is the status of "DICERNA"?
Its status at the CIPO is: registered.
When was "DICERNA" registered?
It was registered on December 5, 2022 and is due to expire on December 5, 2032.
Get this data via the API
Everything on this page comes from the Signa API. Pull DICERNA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deb02-dfc9-7218-9da1-0698c118e04f
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deb02-dfc9-7218-9da1-0698c118e04f",
"object": "trademark",
"mark_text": "DICERNA",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "1929867",
"filing_date": "2018-11-09",
"nice_classes": [
5,
42
],
"owners": [
{
"name": "Dicerna Pharmaceuticals, Inc.",
"entity_id": "ent_019ebbd3-862f-711a-8bfe-d2b68aad05fd"
}
]
}